Jeffrey G. Lamothe insider trades
Open-market stock purchases and sales by Jeffrey G. Lamothe, EVP, COO at Aptevo Therapeutics Inc, from SEC Form 4 filings since Aug 3, 2016.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- APVO Aptevo Therapeutics Inc: other filings, last Aug 6, 2025